In NSCLC cells, overexpression of RBM4 was found to neutralize SRSF1 to inhibit mTOR activation and induce apoptosis by shifting BCL-X splicing to favor the pro-apoptotic BCL-Xs isoform [32]. This evidence concerns the gene BCL2L1 and non-small cell lung carcinoma.